DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dacogen (Decitabine) - Current Clinical Trials

 
 



Dacogen Related Clinical Trials

Phase I/II - Dasatinib and Decitabine [Recruiting]

An Efficacy and Safety Study of Decitabine (DACOGEN) Plus JNJ-56022473 (Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy [Recruiting]

Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients [Active, not recruiting]

Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Recruiting]

Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML [Recruiting]

Study of Ruxolitinib Plus Decitabine in Patients With Acute Myeloid Leukemia (AML) [Recruiting]

Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) [Completed]

Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS) [Completed]

Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC) [Recruiting]

A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) [Completed]

Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS) [Completed]

An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS) [Completed]

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome [Recruiting]

Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer [Completed]

Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma [Terminated]

Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML) [Recruiting]

Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia [Completed]

A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL) [Completed]

Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia [Recruiting]

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS) [Completed]

Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma [Completed]

Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) [Recruiting]

Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS) [Recruiting]

A Leukemia SPORE Phase II Clinical Trial Comparing Decitabine Versus Decitabine/Carboplatin and Decitabine/Arsenic for the Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Active, not recruiting]

Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia [Recruiting]

Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients [Completed]

Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia [Completed]

Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia [Recruiting]

Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk [Recruiting]

An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome [Completed]

10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1 [Recruiting]

Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia [Completed]

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome [Completed]

Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Recruiting]

A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]

Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant [Active, not recruiting]

Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) [Recruiting]

Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Completed]

Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia [Active, not recruiting]

Decitabine, Vorinostat, and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma That Has Relapsed or Not Responded to Treatment [Completed]

Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Completed]

Escalation Study to Determine Bioavailability of a Single Oral Dose of Decitabine in Patients With Myelodysplastic Syndrome (MDS) [Completed]

Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients [Terminated]

Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Terminated]

Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes [Completed]

Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies [Recruiting]

Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia [Recruiting]

Re-expression of ER in Triple Negative Breast Cancers [Terminated]

Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age > 60 [Recruiting]

Low-dose Decitabine for the Treatment of Refractory Immune Thrombocytopenia [Recruiting]

Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes [Recruiting]

Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Completed]

A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome [Completed]

AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia [Active, not recruiting]

Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML) [Active, not recruiting]

Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia [Completed]

DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia [Active, not recruiting]

Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia [Completed]

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [Completed]

Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes [Completed]

Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) [Completed]

Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]

Randomized Phase III Study of Decitabine +/- Hydroxyurea (HY) Versus HY in Advanced Proliferative CMML [Recruiting]

Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases [Completed]

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Active, not recruiting]

An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome [Completed]

Phase I, Dose Escalation Study of Decitabine [Recruiting]

Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease [Recruiting]

Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure [Terminated]

Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML) [Completed]

Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML) [Completed]

Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]

A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes [Completed]

Trial of Decitabine in Patients With Acute Myeloid Leukemia [Completed]

Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors [Terminated]

Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes [Completed]

Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure [Recruiting]

Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib [Recruiting]

A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome [Completed]

Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat [Recruiting]

Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas [Recruiting]

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 [Completed]

Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm [Recruiting]

Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas [Terminated]

Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer [Completed]

Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients [Recruiting]

A Safety and Efficacy Study Using Decitabine, Decitabine/Carboplatin, Decitabine/Arsenic for the Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia , Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia [Recruiting]

Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Recruiting]

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome [Completed]

Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) [Not yet recruiting]

Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma [Completed]

To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS. [Terminated]

Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017